http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 16:23:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html <p> CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. </p><p> To participate in the conference call, interested parties must register in advance by clicking on <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F7e6OCyPvKPtryyYPyURsvUxjwYY%3Fdomain%3Dregister-conf.media-server.com&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=72d986a6fe2b2a751ee4795220626e77" shape="rect">this link</a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation http://www.streetinsider.com/Press+Releases/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html Tue, 16 Jun 2026 16:23:00 -0400 MEDP O.29710626 http://www.streetinsider.com/Press+Releases/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html <p> CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. </p><p> To participate in the conference call, interested parties must register in advance by clicking on <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F7e6OCyPvKPtryyYPyURsvUxjwYY%3Fdomain%3Dregister-conf.media-server.com&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=72d986a6fe2b2a751ee4795220626e77" shape="rect">this link</a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation http://www.streetinsider.com/Press+Releases/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html Tue, 16 Jun 2026 16:23:00 -0400 MEDP O.29710626 http://www.streetinsider.com/Business+Wire/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html <p> CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. </p><p> To participate in the conference call, interested parties must register in advance by clicking on <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F7e6OCyPvKPtryyYPyURsvUxjwYY%3Fdomain%3Dregister-conf.media-server.com&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=72d986a6fe2b2a751ee4795220626e77" shape="rect">this link</a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation http://www.streetinsider.com/Business+Wire/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html Tue, 16 Jun 2026 16:23:00 -0400 MEDP O.29710626 http://www.streetinsider.com/Business+Wire/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html <p> CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. </p><p> To participate in the conference call, interested parties must register in advance by clicking on <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Furl.us.m.mimecastprotect.com%2Fs%2F7e6OCyPvKPtryyYPyURsvUxjwYY%3Fdomain%3Dregister-conf.media-server.com&amp;esheet=54555537&amp;newsitemid=20260616064111&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=72d986a6fe2b2a751ee4795220626e77" shape="rect">this link</a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation http://www.streetinsider.com/Business+Wire/Medpace+Holdings%2C+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+July+22%2C+2026/26654412.html Tue, 16 Jun 2026 16:23:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01++Filed+by%3A+Hansman+Brad+W./26606419.html si-local-file:///var/storage/secattach/20260604/26606419.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01++Filed+by%3A+Hansman+Brad+W./26606419.html Thu, 04 Jun 2026 16:44:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01++Filed+by%3A+Hansman+Brad+W./26606419.html si-local-file:///var/storage/secattach/20260604/26606419.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01++Filed+by%3A+Hansman+Brad+W./26606419.html Thu, 04 Jun 2026 16:44:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01/26605663.html si-local-file:///var/storage/secattach/20260604/26605663.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01/26605663.html Thu, 04 Jun 2026 16:07:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01/26605663.html si-local-file:///var/storage/secattach/20260604/26605663.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Medpace+Holdings%2C+Inc.++++For%3A+Jun+01/26605663.html Thu, 04 Jun 2026 16:07:00 -0400 MEDP O.29710626 http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/General+News/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Medpace+Holdings%2C+Inc.++++For%3A+May+28++Filed+by%3A+EWALD+STEPHEN+P/26584137.html si-local-file:///var/storage/secattach/20260601/26584137.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Medpace+Holdings%2C+Inc.++++For%3A+May+28++Filed+by%3A+EWALD+STEPHEN+P/26584137.html Mon, 01 Jun 2026 16:28:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Medpace+Holdings%2C+Inc.++++For%3A+May+28++Filed+by%3A+EWALD+STEPHEN+P/26584137.html si-local-file:///var/storage/secattach/20260601/26584137.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Medpace+Holdings%2C+Inc.++++For%3A+May+28++Filed+by%3A+EWALD+STEPHEN+P/26584137.html Mon, 01 Jun 2026 16:28:00 -0400 MEDP O.29710626 http://www.streetinsider.com/SEC+Filings/Form++144++++++++Medpace+Holdings%2C+Inc.+++++++++++++++++Filed+by%3A+EWALD+STEPHEN+P/26567260.html si-local-file:///var/storage/secattach/20260528/26567260.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Medpace+Holdings%2C+Inc.+++++++++++++++++Filed+by%3A+EWALD+STEPHEN+P/26567260.html Thu, 28 May 2026 16:07:00 -0400 MEDP O.29710626